Detection of the safe zone for upper eyelid hyaluronic acid injections

dc.authorid0000-0001-7354-4015en_US
dc.contributor.authorCan, Bilgen
dc.contributor.authorGözel, Betül
dc.date.accessioned2023-10-20T11:19:11Z
dc.date.available2023-10-20T11:19:11Z
dc.date.issued2022en_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground: Hyaluronic acid (HA) injections for upper eyelid volumisation are safe procedures with short downtime and low complication rates. Nevertheless, the upper eyelid is a high-risk area for vascular complications because of its rich vascular network. After injection, bruising, an indicator of vascular penetration, develops very often and prolongs the short downtime. Aims: To describe a pain-controlled withdrawal technique for minimizing vascular complications and to examine the effects of topical anaesthesia administered prior to injection on complications related to vascular penetration. Methods: HA was injected into the upper eyelids of 25 patients using the pain-controlled withdrawal technique without topical anaesthesia. The patients' median age, complication rates, average amount of HA administered, and follow-up periods were evaluated. In addition, the patients were asked to evaluate their pain during injection using a numerical pain rating scale. Results: The patients' mean age was 40.4 +/- 7.3 years. Minimal eyelid edema developed in all patients but did not prevent any of the patients' social activities. No bruising was detected in any of the patients, and no major vascular complications, such as blindness or cerebrovascular events, developed. The average amount of HA administered was 1.43 +/- 0.45 cc. All patients evaluated their pain during injection as mild. Conclusions: With the pain-controlled withdrawal technique, none of the patients had minor or major complications due to vascular penetration. The procedure was well tolerated by the patients. The detection of the safe injection zone allowed the administration of more than the standard/accepted 01 cc HA (up to 0.3 cc) from one point.en_US
dc.identifier.doi10.4103/ijd.ijd_787_21
dc.identifier.issn0019-5154
dc.identifier.issn1998-3611
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85135132274
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.4103/ijd.ijd_787_21
dc.identifier.urihttps://hdl.handle.net/20.500.12462/13573
dc.identifier.volume67en_US
dc.identifier.wosWOS:000838720600033
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofIndian Journal of Dermatologyaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBruisingen_US
dc.subjectDeep Superior Sulcus Deformityen_US
dc.subjectInjectionen_US
dc.subjectVascular Complications Techniqueen_US
dc.titleDetection of the safe zone for upper eyelid hyaluronic acid injectionsen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: